(VIANEWS) – Fortress Biotech (FBIOP), B. Riley Financial (RILY), Invesco High Income Trust II (VLT) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Fortress Biotech (FBIOP) | 28.14% | 2024-08-02 03:07:06 |
| B. Riley Financial (RILY) | 10.98% | 2024-08-04 19:42:06 |
| Invesco High Income Trust II (VLT) | 10.57% | 2024-08-11 06:09:26 |
| Teekay Corporation (TK) | 10.1% | 2024-08-10 23:06:05 |
| Nuveen California Dividend Advantage Municipal Fund (NAC) | 7.65% | 2024-08-09 17:09:29 |
| NVE Corporation (NVEC) | 5.05% | 2024-08-15 13:07:05 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Fortress Biotech (FBIOP) – Dividend Yield: 28.14%
Fortress Biotech’s last close was $8.37, 53.5% under its 52-week high of $18.00. Intraday change was 0%.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the treatment of X-linked severe combined immunodeficiency; Cosibelimab for metastatic cancers; CK-101 for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and CEVA101 for the treatment of severe traumatic brain injury in adults and children. The company's early stage product candidates include MB-102 for blastic plasmacytoid dendritic cell neoplasm; MB-101 for glioblastoma; MB-104 for multiple myeloma and light chain amyloidosis; MB-106 for B-cell non-hodgkin lymphoma; MB-103 for GBM & metastatic breast cancer to brain; MB-108; MB-105 for prostate and pancreatic cancers; and BAER-101. Its preclinical product candidates comprise AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; ConVax; and ONCOlogues, and oligonucleotide platform. It has collaboration arrangements with universities, research institutes, and pharmaceutical companies. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York.
Earnings Per Share
As for profitability, Fortress Biotech has a trailing twelve months EPS of $-0.86.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1739.64%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.8%, now sitting on 85.11M for the twelve trailing months.
Volume
Today’s last reported volume for Fortress Biotech is 6538 which is 65.46% below its average volume of 18929.
Yearly Top and Bottom Value
Fortress Biotech’s stock is valued at $8.37 at 20:15 EST, way below its 52-week high of $18.00 and way above its 52-week low of $6.40.
More news about Fortress Biotech.
2. B. Riley Financial (RILY) – Dividend Yield: 10.98%
B. Riley Financial’s last close was $18.21, 67.41% under its 52-week high of $55.88. Intraday change was -4.76%.
B. Riley Financial, Inc., through its subsidiaries, provides investment banking and financial services to corporate, institutional, and high net worth clients in North America, Australia, and Europe. The company operates in six segments: Capital Markets, Wealth Management, Auction and Liquidation, Financial Consulting, Principal Investments–Communications, and Brands. The Capital Markets segments offers investment banking, corporate finance, financial advisory, research, securities lending and sales, and trading services; merger and acquisitions, restructuring advisory, initial and secondary public offerings, and institutional private placements services; asset management services; and trades in equity securities. The Wealth Management segment provides wealth management and tax services. The Auction and Liquidation Segment offers retail store liquidation, and wholesale and industrial assets disposition services. The Financial Consulting segment provides bankruptcy, forensic accounting, litigation support, operations management and real estate consulting, and valuation and appraisal services. The Principal Investments–Communications segment provides consumer Internet access through United Online under the NetZero and Juno brands; VoIP communication and related products, and subscription services through magicJack; and mobile phone services and devices through Marconi Wireless. The Brands segments provides licensing of a brand investment portfolio, including Catherine Malandrino, English Laundry, Joan Vass, Kensie Girl, Limited Too, and Nanette Lepore. It also offers advisory services; brokerage services; senior secured and second lien secured loans to middle market public and the private U.S. companies; and consulting services. The company was formerly known as Great American Group, Inc. and changed its name to B. Riley Financial, Inc. in November 2014. The company was founded in 1973 and is headquartered in Los Angeles, California.
Earnings Per Share
As for profitability, B. Riley Financial has a trailing twelve months EPS of $-5.93.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.19%.
More news about B. Riley Financial.
3. Invesco High Income Trust II (VLT) – Dividend Yield: 10.57%
Invesco High Income Trust II’s last close was $10.94, 0.27% below its 52-week high of $10.97. Intraday change was 0%.
Invesco High Income Trust II is a closed ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc, INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Hong Kong Limited, INVESCO Senior Secured Management, Inc., and Invesco Canada Ltd. It invests in the fixed income markets. The fund seeks to invest in securities rated between BB and C by Standard and Poor's. It seeks to maintain an average duration of around three to four years for its portfolio. The fund benchmarks the performance of its portfolio against the Barclays U.S. Corporate High Yield 2% Issuer Cap Inde. It was formerly known as Invesco Van Kampen High Income Trust II. Invesco High Income Trust II was formed on April 28, 1989 and is domiciled in the United States.
Earnings Per Share
As for profitability, Invesco High Income Trust II has a trailing twelve months EPS of $1.06.
PE Ratio
Invesco High Income Trust II has a trailing twelve months price to earnings ratio of 10.32. Meaning, the purchaser of the share is investing $10.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.17%.
Volume
Today’s last reported volume for Invesco High Income Trust II is 20847 which is 10.33% above its average volume of 18895.
Moving Average
Invesco High Income Trust II’s value is above its 50-day moving average of $10.69 and above its 200-day moving average of $10.45.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 16, 2024, the estimated forward annual dividend rate is 1.16 and the estimated forward annual dividend yield is 10.57%.
Yearly Top and Bottom Value
Invesco High Income Trust II’s stock is valued at $10.94 at 20:15 EST, under its 52-week high of $10.97 and way above its 52-week low of $9.29.
More news about Invesco High Income Trust II.
4. Teekay Corporation (TK) – Dividend Yield: 10.1%
Teekay Corporation’s last close was $7.39, 25.73% below its 52-week high of $9.95. Intraday change was 0.41%.
Teekay Corporation engages in the international crude oil and other marine transportation services worldwide. The company owns and operates crude oil and refined product tankers. It also provides ship-to-ship support services; tanker commercial management operation services; and operational and maintenance marine services. As of March 1, 2024, the company operated a fleet of approximately 53 owned and chartered-in vessels. It serves energy and utility companies, major oil traders, large oil consumers and petroleum product producers, government agencies, and various other entities that depend upon marine transportation. Teekay Corporation was founded in 1973 and is headquartered in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Teekay Corporation has a trailing twelve months EPS of $1.57.
PE Ratio
Teekay Corporation has a trailing twelve months price to earnings ratio of 4.71. Meaning, the purchaser of the share is investing $4.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.24%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 17.5%, now sitting on 1.34B for the twelve trailing months.
More news about Teekay Corporation.
5. Nuveen California Dividend Advantage Municipal Fund (NAC) – Dividend Yield: 7.65%
Nuveen California Dividend Advantage Municipal Fund’s last close was $11.70, 1.35% below its 52-week high of $11.86. Intraday change was 0.17%.
Nuveen California Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of California, United States. The fund invests in undervalued municipal securities and other related investments that are exempt from regular federal and California income taxes. It primarily invests in securities that are rated Baa or BBB or better by Moody's Investors Service, Inc. or Standard & Poor's, and have an average maturity of 20.96 years. The fund employs fundamental analysis with a bottom-up approach to create its portfolio. It benchmarks the performance of its portfolio against the Standard & Poor's (S&P) California Municipal Bond Index and Standard & Poor's (S&P) National Municipal Bond Index. The fund was formerly known as Nuveen California Dividend Advantage Municipal Fund. Nuveen California Quality Municipal Income Fund was formed on December 1, 1998 and is domiciled in the United States.
Earnings Per Share
As for profitability, Nuveen California Dividend Advantage Municipal Fund has a trailing twelve months EPS of $0.77.
PE Ratio
Nuveen California Dividend Advantage Municipal Fund has a trailing twelve months price to earnings ratio of 15.22. Meaning, the purchaser of the share is investing $15.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.07%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.2%, now sitting on 135.37M for the twelve trailing months.
Moving Average
Nuveen California Dividend Advantage Municipal Fund’s worth is above its 50-day moving average of $11.49 and higher than its 200-day moving average of $10.95.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 14, 2024, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 7.65%.
Volume
Today’s last reported volume for Nuveen California Dividend Advantage Municipal Fund is 264799 which is 40.01% below its average volume of 441440.
More news about Nuveen California Dividend Advantage Municipal Fund.
6. NVE Corporation (NVEC) – Dividend Yield: 5.05%
NVE Corporation’s last close was $79.13, 12.31% below its 52-week high of $90.24. Intraday change was 3.97%.
NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data. Its products comprise standard sensors to detect the presence of a magnetic or metallic material to determine position or speed primarily for the factory automation market; and custom and medical sensors for medical devices to replace electromechanical magnetic switches. The company also offers spintronic couplers for industrial Internet of Things market. In addition, it engages in the research and development, and licensing of spintronic magnetoresistive random access memory technology. NVE Corporation was founded in 1989 and is headquartered in Eden Prairie, Minnesota.
Earnings Per Share
As for profitability, NVE Corporation has a trailing twelve months EPS of $3.48.
PE Ratio
NVE Corporation has a trailing twelve months price to earnings ratio of 23.64. Meaning, the purchaser of the share is investing $23.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.59%.
Moving Average
NVE Corporation’s worth is above its 50-day moving average of $77.69 and above its 200-day moving average of $78.07.
Volatility
NVE Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.19%, a negative 0.17%, and a positive 1.86%.
NVE Corporation’s highest amplitude of average volatility was 1.53% (last week), 2.39% (last month), and 1.86% (last quarter).
More news about NVE Corporation.
